$IEX

IDEX CORP /DE/

1
0
0

No SEC Form 4 filings for $IEX in the last 30 days.

See all $IEX insider activity →
Low

Top Research Reports for Cisco, Shopify & Starbucks

Zacks Research Daily features reports on Cisco (CSCO), Shopify (SHOP), and Starbucks (SBUX). Cisco's shares outperformed its industry, driven by demand in networking, security, and AI infrastructure. Shopify's growth is supported by merchant gains and AI tools, despite competition. Starbucks benefits from improving customer traffic and expanding margins, though restructuring costs are a concern.

IEX Launches Revenue Share for Data Vendors

IEX Group launched a vendor partnership program to expand access to its market data, offering revenue sharing for vendors. The program aims to support firms distributing IEX data and aligns with the growth of IEX's equities business. In Q2 2026, IEX had a 4% share of U.S. equity trading volume. The program includes IEX TOPS, DEEP, and DEEP+ products. According to IEX, vendors play a critical role in the market data ecosystem.

IDEX Corporation (IEX) Amends and Restates Credit Agreement, Ext

IDEX Corporation (IEX) amended its credit agreement, extending its debt maturity to 2031 with a $800 million revolving facility. The new agreement, led by Bank of America, provides financial flexibility for working capital and general corporate purposes. The company's GF Value is estimated at $226.10, with a GF Score of 94/100.

IEX sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 1 news story mentioning IEX (IDEX CORP /DE/). Coverage has skewed bullish: 1 bullish, 0 neutral, and 0 bearish.

Recent IEX coverage spans earnings, financial news and corporate actions.

What's driving IEX

AlphAI scores every news story that mentions IEX with an AI model for sentiment and relevance, and aggregates insider trades from IDEX CORP /DE/'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $IEX

Score

Top Research Reports for Cisco, Shopify & Starbucks

Zacks Research Daily features reports on Cisco (CSCO), Shopify (SHOP), and Starbucks (SBUX). Cisco's shares outperformed its industry, driven by demand in networking, security, and AI infrastructure. Shopify's growth is supported by merchant gains and AI tools, despite competition. Starbucks benefits from improving customer traffic and expanding margins, though restructuring costs are a concern.

IEX Launches Revenue Share for Data Vendors

IEX Group launched a vendor partnership program to expand access to its market data, offering revenue sharing for vendors. The program aims to support firms distributing IEX data and aligns with the growth of IEX's equities business. In Q2 2026, IEX had a 4% share of U.S. equity trading volume. The program includes IEX TOPS, DEEP, and DEEP+ products. According to IEX, vendors play a critical role in the market data ecosystem.

$IEXLow

IDEX CORP /DE/ (IEX): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

IDEX CORP /DE/ (IEX) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 – Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On August 13, 2026, L. Paris Watts-Stanfield resigned from the Board of Directors (the “Board”) of IDEX Corporation (the

$IEXMedAI 8/10

IDEX (IEX) Q2 2026 Earnings Call Transcript

IDEX (IEX) reported Q2 2026 net sales of $920.6 million, up 6% reported and 5% organic. Adjusted diluted EPS rose 12% to $2.32. Orders were $1,071.6 million, a record, up 29% reported and 28% organic. Full-year 2026 guidance was raised: organic growth 5% to 6% and EPS $8.70 to $8.85.

$HLTLow

Here Are Wednesday’s Top Wall Street Analyst Research Calls: The Gap, Genmab, Hilton Worldwide, Intuitive Surgical, Marriott International, Merck, Novo Nordisk, Okta, and More

24/7 Wall St. lists Wednesday analyst research calls. Upgrades include Hilton (HLT) to Buy with a $365 target, Intuitive Surgical (ISRG) to Outperform with a $500 target, Merck (MRK) to Outperform with a $143 target, and Okta (OKTA) to Outperform with a $170 target. Downgrades include The Gap (GAP) to Hold, and Novo Nordisk (NVO) to Hold. Initiations cover Genmab (GMAB) and Marriott (MAR).

$IEXHighAI 9/10

IDEX (IEX) Q2 2026 Earnings Call Transcript

IDEX (IEX) Q2 2026 earnings call reported organic revenue growth of 5% and organic orders up 28%. HST led with 47% organic order growth and 12% organic revenue growth. Adjusted EPS was $2.32, above guidance $2.07 to $2.12, and adjusted EBITDA margin rose 70 bps. Free cash flow was $177M, liquidity over $1.1B, and $77M share repurchases. IEEPA tariff refunds added a $0.08 EPS benefit.

Related tickers